Dirk Fluhs
Overview
Explore the profile of Dirk Fluhs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jabbarli L, Fiorentzis M, Rating P, Schmidt B, Biewald E, Guberina N, et al.
Radiat Oncol
. 2025 Feb;
20(1):22.
PMID: 39940039
Objective: Preservation of visual acuity remains a challenging issue after globe sparing therapy of large uveal melanoma. The aim of our study was analyzing the functional outcome after brachytherapy with...
2.
Guberina M, Stuschke M, Fluhs D, Jabbarli L, Kiefer T, Biewald E, et al.
Radiother Oncol
. 2025 Feb;
205:110775.
PMID: 39922315
Background: Dose-response relationships for optic neuropathy and optic nerve atrophy after brachytherapy for posterior uveal melanoma were poorly defined from previous studies. Here, the outcome differences were analyzed in dependence...
3.
Sokolenko E, Fluhs D, Lalos F, Meyer P, Fiorentzis M, Lindziute M, et al.
Can J Ophthalmol
. 2024 May;
59(5):e515-e524.
PMID: 38815956
Objective: To evaluate wolfram as a photon and beta absorber in the management of uveal melanoma with radiotherapy, examining its potential ocular adverse effects and physiologic tolerance using an in...
4.
Jabbarli L, Biewald E, Guberina M, Rating P, Fiorentzis M, Fluhs D, et al.
Eur J Ophthalmol
. 2024 May;
35(1):357-366.
PMID: 38807558
Purpose: Radiation-induced scleral necrosis (RISN) is a less frequent complication of brachytherapy for uveal melanoma, and may require surgical treatment in selected cases. We aimed to identify the prognostic factors...
5.
Lalos F, Fluhs D, Guberina M, Bornfeld N, Stuschke M, Sauerwein W, et al.
Klin Monbl Augenheilkd
. 2024 Feb;
242(2):116-126.
PMID: 38395138
Purpose: To analyze the treatment-related complications after ruthenium-106 brachytherapy in patients with uveal melanoma in terms of radiation-induced optic neuropathy, maculopathy and retinopathy, radiation-related vitreous hemorrhage, and retinal detachment, as...
6.
Lalos F, Fluhs D, Guberina M, Bornfeld N, Stuschke M, Sauerwein W, et al.
Klin Monbl Augenheilkd
. 2024 Feb;
242(2):105-115.
PMID: 38354842
Purpose: The purpose of this study was to analyze tumor-related complications after ruthenium-106 brachytherapy in patients with uveal melanoma, with respect to local tumor control, insufficient radiation response, enucleation, and...
7.
Jabbarli L, Biewald E, Guberina M, Le Guin C, Thomasen H, Fiorentzis M, et al.
Cornea
. 2024 Feb;
43(11):1375-1382.
PMID: 38334485
Purpose: Surgical repair might be required in patients with uveal melanoma (UM) that develop advanced forms of radiation-induced scleral necrosis (RISN). In this monocentric long-term observational study, we aimed at...
8.
Guberina M, Sokolenko E, Guberina N, Dalbah S, Pottgen C, Lubcke W, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230660
The main objective of this prospective observational study was the characterization of the feasibility and early outcome of image-guided (IG) volumetric modulated arc (VMAT) radiosurgery (SRS) followed by resection for...
9.
Schluter S, Bornfeld N, Valiyev E, Fluhs D, Stuschke M, Bechrakis N, et al.
Ocul Oncol Pathol
. 2022 Mar;
8(1):64-70.
PMID: 35356603
Purpose: The aim of this study was to report the efficacy of combined intravitreal chemotherapy (IVC) and ruthenium-106 brachytherapy in retinoblastoma, either as first-line or second-line treatment, following systemic chemoreduction...
10.
Jabbarli L, Guberina M, Biewald E, Fluhs D, Guberina N, Le Guin C, et al.
Clin Exp Ophthalmol
. 2022 Mar;
50(4):466-467.
PMID: 35233900
No abstract available.